These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 32487421)

  • 21. One decade ago, one decade ahead in progressive supranuclear palsy.
    Stamelou M; Giagkou N; Höglinger GU
    Mov Disord; 2019 Sep; 34(9):1284-1293. PubMed ID: 31283855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.
    Wagshal D; Sankaranarayanan S; Guss V; Hall T; Berisha F; Lobach I; Karydas A; Voltarelli L; Scherling C; Heuer H; Tartaglia MC; Miller Z; Coppola G; Ahlijanian M; Soares H; Kramer JH; Rabinovici GD; Rosen HJ; Miller BL; Meredith J; Boxer AL
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):244-50. PubMed ID: 24899730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau immunotherapy in Alzheimer's disease and progressive supranuclear palsy.
    Karimi N; Bayram Çatak F; Arslan E; Saghazadeh A; Rezaei N
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109445. PubMed ID: 36410182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers.
    Parmera JB; Oliveira MCB; Rodrigues RD; Coutinho AM
    Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):126-136. PubMed ID: 35976324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive supranuclear palsy.
    Rehman HU
    Postgrad Med J; 2000 Jun; 76(896):333-6. PubMed ID: 10824045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Progressive Supranuclear Palsy: Past and Present Aspects.
    Parthimos TP; Schulpis KH
    Clin Gerontol; 2020; 43(2):155-180. PubMed ID: 31752626
    [No Abstract]   [Full Text] [Related]  

  • 30. Progressive supranuclear palsy: what do we know about it?
    Long L; Cai XD; Wei XB; Liao JC; Xu YQ; Gao HM; Chen XH; Wang Q
    Curr Med Chem; 2015; 22(10):1182-93. PubMed ID: 25732053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.
    Morgan JC; Ye X; Mellor JA; Golden KJ; Zamudio J; Chiodo LA; Bao Y; Xie T
    J Neurol Sci; 2021 Feb; 421():117293. PubMed ID: 33385754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cerebrospinal fluid microRNA analysis: Progressive supranuclear palsy.
    Nonaka W; Takata T; Iwama H; Komatsubara S; Kobara H; Kamada M; Deguchi K; Touge T; Miyamoto O; Nakamura T; Itano T; Masaki T
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
    Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.
    Respondek G; Roeber S; Kretzschmar H; Troakes C; Al-Sarraj S; Gelpi E; Gaig C; Chiu WZ; van Swieten JC; Oertel WH; Höglinger GU
    Mov Disord; 2013 Apr; 28(4):504-9. PubMed ID: 23436751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.
    Tilley E; McLoughlin J; Koblar SA; Doeltgen SH; Stern C; White S; Peters MD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):148-95. PubMed ID: 27532657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy.
    Moccia M; Picillo M; Erro R; Allocca R; Barone P; Vitale C
    J Neurol Sci; 2015 Mar; 350(1-2):103-4. PubMed ID: 25697711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive supranuclear palsy: diagnosis and management.
    Rowe JB; Holland N; Rittman T
    Pract Neurol; 2021 Oct; 21(5):376-383. PubMed ID: 34215700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging Diagnostic and Therapeutic Strategies for Tauopathies.
    Coughlin D; Irwin DJ
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):72. PubMed ID: 28785992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similarities between familial and sporadic autopsy-proven progressive supranuclear palsy.
    Fujioka S; Algom AA; Murray ME; Strongosky A; Soto-Ortolaza AI; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
    Neurology; 2013 May; 80(22):2076-8. PubMed ID: 23635960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale.
    Pantelyat A; Higginbotham L; Rosenthal L; Lanham D; Nesspor V; AlSalihi M; Bang J; Wang J; Albert M
    Neurodegener Dis; 2020; 20(4):139-146. PubMed ID: 33789283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.